CDNA CareDx Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CDNA

Price (delayed)

$8.08

Market cap

$418.37M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.54

Enterprise value

$363.87M

CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...

Highlights
The debt has declined by 15% year-on-year and by 3.3% since the previous quarter
CareDx's net income has plunged by 148% YoY and by 110% from the previous quarter
CareDx's EPS has plunged by 146% YoY and by 111% from the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.caredx.com
Peers: TTOO AGIO ARDX

Key stats

What are the main financial stats of CDNA
Market
Shares outstanding
51.78M
Market cap
$418.37M
Enterprise value
$363.87M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.67
Price to sales (P/S)
1.55
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.3
Earnings
Revenue
$280.32M
EBIT
-$202.01M
EBITDA
-$182.19M
Free cash flow
-$26.73M
Per share
EPS
-$3.54
Free cash flow per share
-$0.5
Book value per share
$4.83
Revenue per share
$5.21
TBVPS
$7.08
Balance sheet
Total assets
$466.83M
Total liabilities
$205.5M
Debt
$28.28M
Equity
$261.33M
Working capital
$235.64M
Liquidity
Debt to equity
0.11
Current ratio
4.02
Quick ratio
3.68
Net debt/EBITDA
0.3
Margins
EBITDA margin
-65%
Gross margin
63.6%
Net margin
-67.9%
Operating margin
-72.5%
Efficiency
Return on assets
-37.8%
Return on equity
-51.4%
Return on invested capital
-69.1%
Return on capital employed
-52%
Return on sales
-72.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CDNA stock price

How has the CareDx stock price performed over time
Intraday
-2.42%
1 week
-11.6%
1 month
-18.3%
1 year
-10.92%
YTD
-32.67%
QTD
-23.7%

Financial performance

How have CareDx's revenue and profit performed over time
Revenue
$280.32M
Gross profit
$178.33M
Operating income
-$203.36M
Net income
-$190.28M
Gross margin
63.6%
Net margin
-67.9%
The net margin has dropped by 185% year-on-year and by 123% since the previous quarter
The operating income has dropped by 163% year-on-year and by 104% since the previous quarter
CareDx's net income has plunged by 148% YoY and by 110% from the previous quarter
CareDx's operating margin has plunged by 116% from the previous quarter

Growth

What is CareDx's growth rate over time

Valuation

What is CareDx stock price valuation
P/E
N/A
P/B
1.67
P/S
1.55
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.3
CareDx's EPS has plunged by 146% YoY and by 111% from the previous quarter
The stock's price to book (P/B) is 72% less than its 5-year quarterly average of 6.1 but 22% more than its last 4 quarters average of 1.4
The equity has decreased by 39% YoY and by 34% from the previous quarter
The price to sales (P/S) is 80% less than the 5-year quarterly average of 8.0
The revenue has decreased by 13% YoY and by 6% QoQ

Efficiency

How efficient is CareDx business performance
The ROE has plunged by 197% YoY and by 135% from the previous quarter
CareDx's ROS has plunged by 190% YoY and by 112% from the previous quarter
CDNA's return on assets has dropped by 168% year-on-year and by 118% since the previous quarter
The ROIC has shrunk by 147% YoY and by 114% QoQ

Dividends

What is CDNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDNA.

Financial health

How did CareDx financials performed over time
The company's total assets is 127% higher than its total liabilities
CareDx's total liabilities has soared by 92% from the previous quarter and by 83% YoY
The company's quick ratio fell by 22% YoY and by 17% QoQ
The debt is 89% smaller than the equity
CareDx's debt to equity has surged by 57% QoQ and by 38% YoY
The equity has decreased by 39% YoY and by 34% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.